Skip to content
2000
image of Identification of Key lncRNAs and ceRNA Regulatory Networks in Diabetes-Associated Cognitive Dysfunction

Abstract

Introduction

Diabetes clinical guidelines have begun to emphasize the management of cognitive dysfunction in diabetes. Moreover, several studies have shown that long non-coding RNAs (lncRNAs) play critical roles in human diseases. However, no studies have elucidated whether lncRNAs are involved in the pathogenesis of diabetes-associated cognitive dysfunction (DACD).

Methods

The hippocampi of male mice with homozygous leptin receptor-deficient T2DM and their littermates were analyzed high-throughput sequencing. RNA and protein sequencing data were utilized to identify differentially expressed (DE) mRNAs, lncRNAs, and proteins between diabetes mellitus and control groups. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed for DE-mRNAs-DE-proteins. Subsequently, lncRNA-mRNA-pathway and lncRNA-miRNA-mRNA networks were constructed. Quantitative real-time PCR (qRT-PCR) was conducted to verify the expression trends of key lncRNAs in DACD.

Results

We identified upregulated and downregulated mRNAs, lncRNAs, and proteins in the diabetes group. Eleven DE-mRNAs-DE-proteins were associated with inflammatory response, lipid/steroid metabolism, and cell growth. The lncRNA-mRNA-pathway network contained 36 lncRNA-mRNA pairs linked to 8 KEGG pathways. Twenty-five lncRNAs corresponding to Apoa1 were identified as key candidates. Subcellular localization and ceRNA network analyses suggested that lncRNA 3110039I08Rik and lncRNA Gm36445 may regulate DACD. qRT-PCR confirmed their increased expression in diabetic mice.

Discussion

Our findings reveal that lncRNA 3110039108Rik and Gm36445 may act as critical regulators in DACD pathogenesis through competing endogenous RNA (ceRNA) networks. These lncRNAs represent potential biomarkers for early diagnosis and therapeutic targets, offering new insights into the management of cognitive dysfunction in diabetes.

Conclusion

Our results identified two novel lncRNAs that may play critical roles in DACD.

This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cac/10.2174/0115734110374941250717134147
2025-07-28
2025-10-30
Loading full text...

Full text loading...

/deliver/fulltext/cac/10.2174/0115734110374941250717134147/BMS-CAC-2024-HT52-6227-1.html?itemId=/content/journals/cac/10.2174/0115734110374941250717134147&mimeType=html&fmt=ahah

References

  1. Srikanth V. Sinclair A.J. Hill-Briggs F. Moran C. Biessels G.J. Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020 8 6 535 545 10.1016/S2213‑8587(20)30118‑2 32445740
    [Google Scholar]
  2. Ong K.L. Stafford L.K. McLaughlin S.A. Boyko E.J. Vollset S.E. Smith A.E. Dalton B.E. Duprey J. Cruz J.A. Hagins H. Lindstedt P.A. Aali A. Abate Y.H. Abate M.D. Abbasian M. Abbasi-Kangevari Z. Abbasi-Kangevari M. Abd ElHafeez S. Abd-Rabu R. Abdulah D.M. Abdullah A.Y.M. Abedi V. Abidi H. Aboagye R.G. Abolhassani H. Abu-Gharbieh E. Abu-Zaid A. Adane T.D. Adane D.E. Addo I.Y. Adegboye O.A. Adekanmbi V. Adepoju A.V. Adnani Q.E.S. Afolabi R.F. Agarwal G. Aghdam Z.B. Agudelo-Botero M. Aguilera Arriagada C.E. Agyemang-Duah W. Ahinkorah B.O. Ahmad D. Ahmad R. Ahmad S. Ahmad A. Ahmadi A. Ahmadi K. Ahmed A. Ahmed A. Ahmed L.A. Ahmed S.A. Ajami M. Akinyemi R.O. Al Hamad H. Al Hasan S.M. AL-Ahdal, T.M.A.; Alalwan, T.A.; Al-Aly, Z.; AlBataineh, M.T.; Alcalde-Rabanal, J.E.; Alemi, S.; Ali, H.; Alinia, T.; Aljunid, S.M.; Almustanyir, S.; Al-Raddadi, R.M.; Alvis-Guzman, N.; Amare, F.; Ameyaw, E.K.; Amiri, S.; Amusa, G.A.; Andrei, C.L.; Anjana, R.M.; Ansar, A.; Ansari, G.; Ansari-Moghaddam, A.; Anyasodor, A.E.; Arabloo, J.; Aravkin, A.Y.; Areda, D.; Arifin, H.; Arkew, M.; Armocida, B.; Ärnlöv, J.; Artamonov, A.A.; Arulappan, J.; Aruleba, R.T.; Arumugam, A.; Aryan, Z.; Asemu, M.T.; Asghari-Jafarabadi, M.; Askari, E.; Asmelash, D.; Astell-Burt, T.; Athar, M.; Athari, S.S.; Atout, M.M.W.; Avila-Burgos, L.; Awaisu, A.; Azadnajafabad, S.; B, D.B.; Babamohamadi, H.; Badar, M.; Badawi, A.; Badiye, A.D.; Baghcheghi, N.; Bagheri, N.; Bagherieh, S.; Bah, S.; Bahadory, S.; Bai, R.; Baig, A.A.; Baltatu, O.C.; Baradaran, H.R.; Barchitta, M.; Bardhan, M.; Barengo, N.C.; Bärnighausen, T.W.; Barone, M.T.U.; Barone-Adesi, F.; Barrow, A.; Bashiri, H.; Basiru, A.; Basu, S.; Basu, S.; Batiha, A-M.M.; Batra, K.; Bayih, M.T.; Bayileyegn, N.S.; Behnoush, A.H.; Bekele, A.B.; Belete, M.A.; Belgaumi, U.I.; Belo, L.; Bennett, D.A.; Bensenor, I.M.; Berhe, K.; Berhie, A.Y.; Bhaskar, S.; Bhat, A.N.; Bhatti, J.S.; Bikbov, B.; Bilal, F.; Bintoro, B.S.; Bitaraf, S.; Bitra, V.R.; Bjegovic-Mikanovic, V.; Bodolica, V.; Boloor, A.; Brauer, M.; Brazo-Sayavera, J.; Brenner, H.; Butt, Z.A.; Calina, D.; Campos, L.A.; Campos-Nonato, I.R.; Cao, Y.; Cao, C.; Car, J.; Carvalho, M.; Castañeda-Orjuela, C.A.; Catalá-López, F.; Cerin, E.; Chadwick, J.; Chandrasekar, E.K.; Chanie, G.S.; Charan, J.; Chattu, V.K.; Chauhan, K.; Cheema, H.A.; Chekol Abebe, E.; Chen, S.; Cherbuin, N.; Chichagi, F.; Chidambaram, S.B.; Cho, W.C.S.; Choudhari, S.G.; Chowdhury, R.; Chowdhury, E.K.; Chu, D-T.; Chukwu, I.S.; Chung, S-C.; Coberly, K.; Columbus, A.; Contreras, D.; Cousin, E.; Criqui, M.H.; Cruz-Martins, N.; Cuschieri, S.; Dabo, B.; Dadras, O.; Dai, X.; Damasceno, A.A.M.; Dandona, R.; Dandona, L.; Das, S.; Dascalu, A.M.; Dash, N.R.; Dashti, M.; Dávila-Cervantes, C.A.; De la Cruz-Góngora, V.; Debele, G.R.; Delpasand, K.; Demisse, F.W.; Demissie, G.D.; Deng, X.; Denova-Gutiérrez, E.; Deo, S.V.; Dervišević, E.; Desai, H.D.; Desale, A.T.; Dessie, A.M.; Desta, F.; Dewan, S.M.R.; Dey, S.; Dhama, K.; Dhimal, M.; Diao, N.; Diaz, D.; Dinu, M.; Diress, M.; Djalalinia, S.; Doan, L.P.; Dongarwar, D.; dos Santos Figueiredo, F.W.; Duncan, B.B.; Dutta, S.; Dziedzic, A.M.; Edinur, H.A.; Ekholuenetale, M.; Ekundayo, T.C.; Elgendy, I.Y.; Elhadi, M.; El-Huneidi, W.; Elmeligy, O.A.A.; Elmonem, M.A.; Endeshaw, D.; Esayas, H.L.; Eshetu, H.B.; Etaee, F.; Fadhil, I.; Fagbamigbe, A.F.; Fahim, A.; Falahi, S.; Faris, M.A.I.E.M.; Farrokhpour, H.; Farzadfar, F.; Fatehizadeh, A.; Fazli, G.; Feng, X.; Ferede, T.Y.; Fischer, F.; Flood, D.; Forouhari, A.; Foroumadi, R.; Foroutan Koudehi, M.; Gaidhane, A.M.; Gaihre, S.; Gaipov, A.; Galali, Y.; Ganesan, B.; Garcia-Gordillo, M.A.; Gautam, R.K.; Gebrehiwot, M.; Gebrekidan, K.G.; Gebremeskel, T.G.; Getacher, L.; Ghadirian, F.; Ghamari, S-H.; Ghasemi Nour, M.; Ghassemi, F.; Golechha, M.; Goleij, P.; Golinelli, D.; Gopalani, S.V.; Guadie, H.A.; Guan, S-Y.; Gudayu, T.W.; Guimarães, R.A.; Guled, R.A.; Gupta, R.; Gupta, K.; Gupta, V.B.; Gupta, V.K.; Gyawali, B.; Haddadi, R.; Hadi, N.R.; Haile, T.G.; Hajibeygi, R.; Haj-Mirzaian, A.; Halwani, R.; Hamidi, S.; Hankey, G.J.; Hannan, M.A.; Haque, S.; Harandi, H.; Harlianto, N.I.; Hasan, S.M.M.; Hasan, S.S.; Hasani, H.; Hassanipour, S.; Hassen, M.B.; Haubold, J.; Hayat, K.; Heidari, G.; Heidari, M.; Hessami, K.; Hiraike, Y.; Holla, R.; Hossain, S.; Hossain, M.S.; Hosseini, M-S.; Hosseinzadeh, M.; Hosseinzadeh, H.; Huang, J.; Huda, M.N.; Hussain, S.; Huynh, H-H.; Hwang, B-F.; Ibitoye, S.E.; Ikeda, N.; Ilic, I.M.; Ilic, M.D.; Inbaraj, L.R.; Iqbal, A.; Islam, S.M.S.; Islam, R.M.; Ismail, N.E.; Iso, H.; Isola, G.; Itumalla, R.; Iwagami, M.; Iwu, C.C.D.; Iyamu, I.O.; Iyasu, A.N.; Jacob, L.; Jafarzadeh, A.; Jahrami, H.; Jain, R.; Jaja, C.; Jamalpoor, Z.; Jamshidi, E.; Janakiraman, B.; Jayanna, K.; Jayapal, S.K.; Jayaram, S.; Jayawardena, R.; Jebai, R.; Jeong, W.; Jin, Y.; Jokar, M.; Jonas, J.B.; Joseph, N.; Joseph, A.; Joshua, C.E.; Joukar, F.; Jozwiak, J.J.; Kaambwa, B.; Kabir, A.; Kabthymer, R.H.; Kadashetti, V.; Kahe, F.; Kalhor, R.; Kandel, H.; Karanth, S.D.; Karaye, I.M.; Karkhah, S.; Katoto, P.D.M.C.; Kaur, N.; Kazemian, S.; Kebede, S.A.; Khader, Y.S.; Khajuria, H.; Khalaji, A.; Khan, M.A.B.; Khan, M.; Khan, A.; Khanal, S.; Khatatbeh, M.M.; Khater, A.M.; Khateri, S.; khorashadizadeh, F.; Khubchandani, J.; Kibret, B.G.; Kim, M.S.; Kimokoti, R.W.; Kisa, A.; Kivimäki, M.; Kolahi, A-A.; Komaki, S.; Kompani, F.; Koohestani, H.R.; Korzh, O.; Kostev, K.; Kothari, N.; Koyanagi, A.; Krishan, K.; Krishnamoorthy, Y.; Kuate Defo, B.; Kuddus, M.; Kuddus, M.A.; Kumar, R.; Kumar, H.; Kundu, S.; Kurniasari, M.D.; Kuttikkattu, A.; La Vecchia, C.; Lallukka, T.; Larijani, B.; Larsson, A.O.; Latief, K.; Lawal, B.K.; Le, T.T.T.; Le, T.T.B.; Lee, S.W.H.; Lee, M.; Lee, W-C.; Lee, P.H.; Lee, S.; Lee, S.W.; Legesse, S.M.; Lenzi, J.; Li, Y.; Li, M-C.; Lim, S.S.; Lim, L-L.; Liu, X.; Liu, C.; Lo, C-H.; Lopes, G.; Lorkowski, S.; Lozano, R.; Lucchetti, G.; Maghazachi, A.A.; Mahasha, P.W.; Mahjoub, S.; Mahmoud, M.A.; Mahmoudi, R.; Mahmoudimanesh, M.; Mai, A.T.; Majeed, A.; Majma Sanaye, P.; Makris, K.C.; Malhotra, K.; Malik, A.A.; Malik, I.; Mallhi, T.H.; Malta, D.C.; Mamun, A.A.; Mansouri, B.; Marateb, H.R.; Mardi, P.; Martini, S.; Martorell, M.; Marzo, R.R.; Masoudi, R.; Masoudi, S.; Mathews, E.; Maugeri, A.; Mazzaglia, G.; Mekonnen, T.; Meshkat, M.; Mestrovic, T.; Miao Jonasson, J.; Miazgowski, T.; Michalek, I.M.; Minh, L.H.N.; Mini, G.K.; Miranda, J.J.; Mirfakhraie, R.; Mirrakhimov, E.M.; Mirza-Aghazadeh-Attari, M.; Misganaw, A.; Misgina, K.H.; Mishra, M.; Moazen, B.; Mohamed, N.S.; Mohammadi, E.; Mohammadi, M.; Mohammadian-Hafshejani, A.; Mohammadshahi, M.; Mohseni, A.; Mojiri-forushani, H.; Mokdad, A.H.; Momtazmanesh, S.; Monasta, L.; Moniruzzaman, M.; Mons, U.; Montazeri, F.; Moodi Ghalibaf, A.A.; Moradi, Y.; Moradi, M.; Moradi Sarabi, M.; Morovatdar, N.; Morrison, S.D.; Morze, J.; Mossialos, E.; Mostafavi, E.; Mueller, U.O.; Mulita, F.; Mulita, A.; Murillo-Zamora, E.; Musa, K.I.; Mwita, J.C.; Nagaraju, S.P.; Naghavi, M.; Nainu, F.; Nair, T.S.; Najmuldeen, H.H.R.; Nangia, V.; Nargus, S.; Naser, A.Y.; Nassereldine, H.; Natto, Z.S.; Nauman, J.; Nayak, B.P.; Ndejjo, R.; Negash, H.; Negoi, R.I.; Nguyen, H.T.H.; Nguyen, D.H.; Nguyen, P.T.; Nguyen, V.T.; Nguyen, H.Q.; Niazi, R.K.; Nigatu, Y.T.; Ningrum, D.N.A.; Nizam, M.A.; Nnyanzi, L.A.; Noreen, M.; Noubiap, J.J.; Nzoputam, O.J.; Nzoputam, C.I.; Oancea, B.; Odogwu, N.M.; Odukoya, O.O.; Ojha, V.A.; Okati-Aliabad, H.; Okekunle, A.P.; Okonji, O.C.; Okwute, P.G.; Olufadewa, I.I.; Onwujekwe, O.E.; Ordak, M.; Ortiz, A.; Osuagwu, U.L.; Oulhaj, A.; Owolabi, M.O.; Padron-Monedero, A.; Padubidri, J.R.; Palladino, R.; Panagiotakos, D.; Panda-Jonas, S.; Pandey, A.; Pandey, A.; Pandi-Perumal, S.R.; Pantea Stoian, A.M.; Pardhan, S.; Parekh, T.; Parekh, U.; Pasovic, M.; Patel, J.; Patel, J.R.; Paudel, U.; Pepito, V.C.F.; Pereira, M.; Perico, N.; Perna, S.; Petcu, I-R.; Petermann-Rocha, F.E.; Podder, V.; Postma, M.J.; Pourali, G.; Pourtaheri, N.; Prates, E.J.S.; Qadir, M.M.F.; Qattea, I.; Raee, P.; Rafique, I.; Rahimi, M.; Rahimifard, M.; Rahimi-Movaghar, V.; Rahman, M.O.; Rahman, M.A.; Rahman, M.H.U.; Rahman, M.; Rahman, M.M.; Rahmani, M.; Rahmani, S.; Rahmanian, V.; Rahmawaty, S.; Rahnavard, N.; Rajbhandari, B.; Ram, P.; Ramazanu, S.; Rana, J.; Rancic, N.; Ranjha, M.M.A.N.; Rao, C.R.; Rapaka, D.; Rasali, D.P.; Rashedi, S.; Rashedi, V.; Rashid, A.M.; Rashidi, M-M.; Ratan, Z.A.; Rawaf, S.; Rawal, L.; Redwan, E.M.M.; Remuzzi, G.; Rengasamy, K.R.R.; Renzaho, A.M.N.; Reyes, L.F.; Rezaei, N.; Rezaei, N.; Rezaeian, M.; Rezazadeh, H.; Riahi, S.M.; Rias, Y.A.; Riaz, M.; Ribeiro, D.; Rodrigues, M.; Rodriguez, J.A.B.; Roever, L.; Rohloff, P.; Roshandel, G.; Roustazadeh, A.; Rwegerera, G.M.; Saad, A.M.A.; Saber-Ayad, M.M.; Sabour, S.; Sabzmakan, L.; Saddik, B.; Sadeghi, E.; Saeed, U.; Saeedi Moghaddam, S.; Safi, S.; Safi, S.Z.; Saghazadeh, A.; Saheb Sharif-Askari, N.; Saheb Sharif-Askari, F.; Sahebkar, A.; Sahoo, S.S.; Sahoo, H.; Saif-Ur-Rahman, K.M.; Sajid, M.R.; Salahi, S.; Salahi, S.; Saleh, M.A.; Salehi, M.A.; Salomon, J.A.; Sanabria, J.; Sanjeev, R.K.; Sanmarchi, F.; Santric-Milicevic, M.M.; Sarasmita, M.A.; Sargazi, S.; Sathian, B.; Sathish, T.; Sawhney, M.; Schlaich, M.P.; Schmidt, M.I.; Schuermans, A.; Seidu, A-A.; Senthil Kumar, N.; Sepanlou, S.G.; Sethi, Y.; Seylani, A.; Shabany, M.; Shafaghat, T.; Shafeghat, M.; Shafie, M.; Shah, N.S.; Shahid, S.; Shaikh, M.A.; Shanawaz, M.; Shannawaz, M.; Sharfaei, S.; Shashamo, B.B.; Shiri, R.; Shittu, A.; Shivakumar, K.M.; Shivalli, S.; Shobeiri, P.; Shokri, F.; Shuval, K.; Sibhat, M.M.; Silva, L.M.L.R.; Simpson, C.R.; Singh, J.A.; Singh, P.; Singh, S.; Siraj, M.S.; Skryabina, A.A.; Sohag, A.A.M.; Soleimani, H.; Solikhah, S.; Soltani-Zangbar, M.S.; Somayaji, R.; Sorensen, R.J.D.; Starodubova, A.V.; Sujata, S.; Suleman, M.; Sun, J.; Sundström, J.; Tabarés-Seisdedos, R.; Tabatabaei, S.M.; Tabatabaeizadeh, S-A.; Tabish, M.; Taheri, M.; Taheri, E.; Taki, E.; Tamuzi, J.J.L.L.; Tan, K-K.; Tat, N.Y.; Taye, B.T.; Temesgen, W.A.; Temsah, M-H.; Tesler, R.; Thangaraju, P.; Thankappan, K.R.; Thapa, R.; Tharwat, S.; Thomas, N.; Ticoalu, J.H.V.; Tiyuri, A.; Tonelli, M.; Tovani-Palone, M.R.; Trico, D.; Trihandini, I.; Tripathy, J.P.; Tromans, S.J.; Tsegay, G.M.; Tualeka, A.R.; Tufa, D.G.; Tyrovolas, S.; Ullah, S.; Upadhyay, E.; Vahabi, S.M.; Vaithinathan, A.G.; Valizadeh, R.; van Daalen, K.R.; Vart, P.; Varthya, S.B.; Vasankari, T.J.; Vaziri, S.; Verma, M.; Verras, G-I.; Vo, D.C.; Wagaye, B.; Waheed, Y.; Wang, Z.; Wang, Y.; Wang, C.; Wang, F.; Wassie, G.T.; Wei, M.Y.W.; Weldemariam, A.H.; Westerman, R.; Wickramasinghe, N.D.; Wu, Y.F.; Wulandari, R.D.W.I.; Xia, J.; Xiao, H.; Xu, S.; Xu, X.; Yada, D.Y.; Yang, L.; Yatsuya, H.; Yesiltepe, M.; Yi, S.; Yohannis, H.K.; Yonemoto, N.; You, Y.; Zaman, S.B.; Zamora, N.; Zare, I.; Zarea, K.; Zarrintan, A.; Zastrozhin, M.S.; Zeru, N.G.; Zhang, Z-J.; Zhong, C.; Zhou, J.; Zielińska, M.; Zikarg, Y.T.; Zodpey, S.; Zoladl, M.; Zou, Z.; Zumla, A.; Zuniga, Y.M.H.; Magliano, D.J.; Murray, C.J.L.; Hay, S.I.; Vos, T. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023 402 10397 203 234 10.1016/S0140‑6736(23)01301‑6 37356446
    [Google Scholar]
  3. van Sloten T.T. Sedaghat S. Carnethon M.R. Launer L.J. Stehouwer C.D.A. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020 8 4 325 336 10.1016/S2213‑8587(19)30405‑X 32135131
    [Google Scholar]
  4. Aderinto N. Olatunji G. Abdulbasit M. The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations. Medicine 2023 102 43 e35557 10.1097/MD.0000000000035557
    [Google Scholar]
  5. Djebali S. Davis C.A. Merkel A. Dobin A. Lassmann T. Mortazavi A. Tanzer A. Lagarde J. Lin W. Schlesinger F. Xue C. Marinov G.K. Khatun J. Williams B.A. Zaleski C. Rozowsky J. Röder M. Kokocinski F. Abdelhamid R.F. Alioto T. Antoshechkin I. Baer M.T. Bar N.S. Batut P. Bell K. Bell I. Chakrabortty S. Chen X. Chrast J. Curado J. Derrien T. Drenkow J. Dumais E. Dumais J. Duttagupta R. Falconnet E. Fastuca M. Fejes-Toth K. Ferreira P. Foissac S. Fullwood M.J. Gao H. Gonzalez D. Gordon A. Gunawardena H. Howald C. Jha S. Johnson R. Kapranov P. King B. Kingswood C. Luo O.J. Park E. Persaud K. Preall J.B. Ribeca P. Risk B. Robyr D. Sammeth M. Schaffer L. See L.H. Shahab A. Skancke J. Suzuki A.M. Takahashi H. Tilgner H. Trout D. Walters N. Wang H. Wrobel J. Yu Y. Ruan X. Hayashizaki Y. Harrow J. Gerstein M. Hubbard T. Reymond A. Antonarakis S.E. Hannon G. Giddings M.C. Ruan Y. Wold B. Carninci P. Guigó R. Gingeras T.R. Landscape of transcription in human cells. Nature 2012 489 7414 101 108 10.1038/nature11233 22955620
    [Google Scholar]
  6. Mattick J.S. Amaral P.P. Carninci P. Carpenter S. Chang H.Y. Chen L.L. Chen R. Dean C. Dinger M.E. Fitzgerald K.A. Gingeras T.R. Guttman M. Hirose T. Huarte M. Johnson R. Kanduri C. Kapranov P. Lawrence J.B. Lee J.T. Mendell J.T. Mercer T.R. Moore K.J. Nakagawa S. Rinn J.L. Spector D.L. Ulitsky I. Wan Y. Wilusz J.E. Wu M. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 2023 24 6 430 447 10.1038/s41580‑022‑00566‑8 36596869
    [Google Scholar]
  7. Nemeth K. Bayraktar R. Ferracin M. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat. Rev. Genet. 2023 ••• 15 Epub ahead of print10.1038/s41576‑023‑00662‑1 37968332
    [Google Scholar]
  8. Pandey A. Ajgaonkar S. Jadhav N. Saha P. Gurav P. Panda S. Mehta D. Nair S. Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. Pharmaceuticals 2022 15 10 1269 Epub ahead of print10.3390/ph15101269 36297381
    [Google Scholar]
  9. Hoorzad P. Mousavinasab F. Tofigh P. Kalahroud E.M. Aghaei-Zarch S.M. Salehi A. Fattahi M. Le B.N. Understanding the lncRNA/miRNA-NFκB regulatory network in diabetes mellitus: From function to clinical translation. Diabetes Res. Clin. Pract. 2023 202 110804 Epub ahead of print10.1016/j.diabres.2023.110804 37369279
    [Google Scholar]
  10. Lu X. Tan Q. Ma J. Zhang J. Yu P. Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications. Front. Cell Dev. Biol. 2022 9 792401 Epub ahead of print10.3389/fcell.2021.792401 35087834
    [Google Scholar]
  11. Wang Z. Xia P. Hu J. Huang Y. Zhang F. Li L. Wang E. Guo Q. Ye Z. LncRNA MEG3 Alleviates Diabetic Cognitive Impairments by Reducing Mitochondrial-Derived Apoptosis through Promotion of FUNDC1-Related Mitophagy via Rac1-ROS Axis. ACS Chem. Neurosci. 2021 12 13 2280 2307 10.1021/acschemneuro.0c00682 33843209
    [Google Scholar]
  12. Du P. Wang J. Han Y. Feng J. Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 Axis Inhibits the Hippocampal Inflammatory Response in T2DM With OSA. Front. Cell. Neurosci. 2020 14 97 10.3389/fncel.2020.00097 32477065
    [Google Scholar]
  13. Jiang L. Yuan N. Zhao N. Tian P. Zhang D. Qin Y. Shi Z. Gao Z. Zhang N. Zhou H. Zhang R. Xu S. Advanced glycation end products induce Aβ1–42 deposition and cognitive decline through H19/miR-15b/BACE1 axis in diabetic encephalopathy. Brain Res. Bull. 2022 188 187 196 10.1016/j.brainresbull.2022.08.007 35961529
    [Google Scholar]
  14. Xiang Q. Lin H. Tao J.S. Fu C.J. Liu L.N. Deng J. Li X.H. MiR-18a-LncRNA NONRATG-022419 pairs targeted PRG-1 regulates diabetic induced cognitive impairment by regulating NGFTrkb signaling pathway. Proteome Sci. 2025 23 1 1 15 10.1186/s12953‑025‑00239‑2 39915794
    [Google Scholar]
  15. Li Z. Hao S. Yin H. Gao J. Yang Z. Autophagy ameliorates cognitive impairment through activation of PVT1 and apoptosis in diabetes mice. Behav. Brain Res. 2016 305 265 277 10.1016/j.bbr.2016.03.023 26971628
    [Google Scholar]
  16. Hao L. Li Q. Zhao X. Li Y. Zhang C. A long noncoding RNA LOC103690121 promotes hippocampus neuronal apoptosis in streptozotocin-induced type 1 diabetes. Neurosci. Lett. 2019 703 11 18 10.1016/j.neulet.2019.03.006 30851305
    [Google Scholar]
  17. Li Y. Jiang T. Du M. He S. Huang N. Cheng B. Yan C. Tang W. Gao W. Guo H. Li Q. Wang Q. Ketohexokinase-dependent metabolism of cerebral endogenous fructose in microglia drives diabetes-associated cognitive dysfunction. Exp. Mol. Med. 2023 55 11 2417 2432 10.1038/s12276‑023‑01112‑y 37907746
    [Google Scholar]
  18. Wang J. Shen C. Dong D. Zhong X. Wang Y. Yang X. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer. Int. Immunopharmacol. 2021 90 107146 10.1016/j.intimp.2020.107146 33189610
    [Google Scholar]
  19. Lin M.F. Jungreis I. Kellis M. PhyloCSF: a comparative genomics method to distinguish protein coding and non-coding regions. Bioinformatics 2011 27 13 i275 i282 10.1093/bioinformatics/btr209 21685081
    [Google Scholar]
  20. Cole J.B. Florez J.C. Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 2020 16 7 377 390 10.1038/s41581‑020‑0278‑5 32398868
    [Google Scholar]
  21. Roberts R.O. Knopman D.S. Przybelski S.A. Mielke M.M. Kantarci K. Preboske G.M. Senjem M.L. Pankratz V.S. Geda Y.E. Boeve B.F. Ivnik R.J. Rocca W.A. Petersen R.C. Jack C.R. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 2014 82 13 1132 1141 10.1212/WNL.0000000000000269 24647028
    [Google Scholar]
  22. Xue M. Xu W. Ou Y.N. Cao X.P. Tan M.S. Tan L. Yu J.T. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res. Rev. 2019 55 100944 Epub ahead of print10.1016/j.arr.2019.100944 31430566
    [Google Scholar]
  23. Yu X. He H. Wen J. Xu X. Ruan Z. Hu R. Wang F. Ju H. Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments. Open Med. (Wars.) 2025 20 1 20241091 10.1515/med‑2024‑1091 39822993
    [Google Scholar]
  24. Cao Z. Pan X. Yang Y. Huang Y. Shen H.B. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics 2018 34 13 2185 2194 10.1093/bioinformatics/bty085 29462250
    [Google Scholar]
  25. Wang W. Min L. Qiu X. Wu X. Liu C. Ma J. Zhang D. Zhu L. Biological Function of Long Non-coding RNA (LncRNA). Xist. Front Cell. Dev. Biol. 2021 9 645647 Epub ahead of print10.3389/fcell.2021.645647 34178980
    [Google Scholar]
  26. Anita N.Z. Zebarth J. Chan B. Wu C.Y. Syed T. Shahrul D. Nguyen M.M. Pakosh M. Herrmann N. Lanctôt K.L. Swardfager W. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis. Brain Behav. Immun. 2022 100 55 69 10.1016/j.bbi.2021.11.005 34808290
    [Google Scholar]
  27. Goldberg R.B. Dyslipidemia in Diabetes. Endocrinol. Metab. Clin. North Am. 2022 51 3 603 624 10.1016/j.ecl.2022.02.011 35963631
    [Google Scholar]
  28. Horton W.B. Barrett E.J. Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease. Endocr. Rev. 2021 42 1 29 55 10.1210/endrev/bnaa025 33125468
    [Google Scholar]
  29. Iadecola C. Duering M. Hachinski V. Joutel A. Pendlebury S.T. Schneider J.A. Dichgans M. Vascular Cognitive Impairment and Dementia. J. Am. Coll. Cardiol. 2019 73 25 3326 3344 10.1016/j.jacc.2019.04.034 31248555
    [Google Scholar]
  30. Rao W. Zhang Y. Li K. Zhang X.Y. Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia. Aging (Albany NY) 2021 13 12 16353 16366 10.18632/aging.203161 34135129
    [Google Scholar]
  31. Koch M. DeKosky S.T. Goodman M. Sun J. Furtado J.D. Fitzpatrick A.L. Mackey R.H. Cai T. Lopez O.L. Kuller L.H. Mukamal K.J. Jensen M.K. High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia. J. Lipid Res. 2020 61 3 445 454 10.1194/jlr.P119000473 31892526
    [Google Scholar]
  32. Cochran B.J. Ong K-L. Manandhar B. APOA1: a Protein with Multiple Therapeutic Functions. Curr. Atheroscler. Rep. 2021 23 3 11 10.1007/s11883‑021‑00906‑7
    [Google Scholar]
  33. Pittas A.G. Kawahara T. Jorde R. Dawson-Hughes B. Vickery E.M. Angellotti E. Nelson J. Trikalinos T.A. Balk E.M. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes. Ann. Intern. Med. 2023 176 3 355 363 10.7326/M22‑3018 36745886
    [Google Scholar]
  34. Yan M.K.W. Khalil H. Vitamin supplements in type 2 diabetes mellitus management: A review. Diabetes Metab. Syndr 2017 11 S589 S595.(Suppl. 2) 10.1016/j.dsx.2017.04.009 28420574
    [Google Scholar]
  35. Zuin M. Cervellati C. Trentini A. Passaro A. Rosta V. Zimetti F. Zuliani G. Association between serum concentrations of apolipoprotein a-i (Apoa-i) and alzheimer’s disease: Systematic review and meta-analysis. Diagnostics 2021 11 6 984 Epub ahead of print 10.3390/diagnostics11060984 34071695
    [Google Scholar]
  36. Slot R.E.R. Van Harten A.C. Kester M.I. Jongbloed W. Bouwman F.H. Teunissen C.E. Scheltens P. Veerhuis R. van der Flier W.M. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly. J. Alzheimers Dis. 2017 56 2 687 697 10.3233/JAD‑151068 28035918
    [Google Scholar]
  37. Stoye N.M. Jung P. Guilherme M.S. Lotz J. Fellgiebel A. Endres K. Apolipoprotein A1 in Cerebrospinal Fluid Is Insufficient to Distinguish Alzheimer’s Disease from Other Dementias in a Naturalistic, Clinical Setting. J. Alzheimers Dis. Rep. 2020 4 1 15 19 10.3233/ADR‑190165 32206754
    [Google Scholar]
  38. Ahmed S.S. Al Nohair S.F. Abdulmonem W.A. Alhomaidan H.T. Rasheed N. Ismail M.S. Albatanony M.A. Rasheed Z. Honey polyphenolic fraction inhibits cyclooxygenase-2 expression via upregulation of microRNA-26a-5p expression in pancreatic islets. Eur. J. Inflamm. 2022 20 20587392221076473 10.1177/20587392221076473
    [Google Scholar]
  39. Zhang L. Li M. Zhan L. Lu X. Liang L. Su B. Sui H. Gao Z. Li Y. Liu Y. Wu B. Liu Q. Plasma metabolomic profiling of patients with diabetes-associated cognitive decline. PLoS One 2015 10 5 e0126952 10.1371/journal.pone.0126952 25974350
    [Google Scholar]
  40. Walter R.M. Uriu-Hare J.Y. Olin K.L. Oster M.H. Anawalt B.D. Critchfield J.W. Keen C.L. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991 14 11 1050 1056 10.2337/diacare.14.11.1050 1797486
    [Google Scholar]
  41. Luo A. Xie Z. Wang Y. Wang X. Li S. Yan J. Zhan G. Zhou Z. Zhao Y. Li S. Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies. Neurosci. Biobehav. Rev. 2022 137 104642 10.1016/j.neubiorev.2022.104642 35367221
    [Google Scholar]
  42. Arnold S.E. Arvanitakis Z. Macauley-Rambach S.L. Koenig A.M. Wang H.Y. Ahima R.S. Craft S. Gandy S. Buettner C. Stoeckel L.E. Holtzman D.M. Nathan D.M. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 2018 14 3 168 181 10.1038/nrneurol.2017.185 29377010
    [Google Scholar]
  43. Salmena L. Poliseno L. Tay Y. Kats L. Pandolfi P.P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011 146 3 353 358 10.1016/j.cell.2011.07.014 21802130
    [Google Scholar]
  44. Rafiee A. Riazi-Rad F. Havaskary M. Nuri F. Long noncoding RNAs: regulation, function and cancer. Biotechnol. Genet. Eng. Rev. 2018 34 2 153 180 10.1080/02648725.2018.1471566 30071765
    [Google Scholar]
  45. Arunkumar G. LncRNAs: the good, the bad, and the unknown. Biochem. Cell Biol. 2024 102 1 9 27 10.1139/bcb‑2023‑0155 37579511
    [Google Scholar]
  46. Schmitz S.U. Grote P. Herrmann B.G. Mechanisms of long noncoding RNA function in development and disease. Cell. Mol. Life Sci. 2016 73 13 2491 2509 10.1007/s00018‑016‑2174‑5 27007508
    [Google Scholar]
  47. Forrest M.E. Khalil A.M. Review: Regulation of the cancer epigenome by long non-coding RNAs. Cancer Lett. 2017 407 106 112 10.1016/j.canlet.2017.03.040 28400335
    [Google Scholar]
  48. Banks W.A. Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology 2012 153 9 4111 4119 10.1210/en.2012‑1435 22778219
    [Google Scholar]
  49. Nation D.A. Sweeney M.D. Montagne A. Sagare A.P. D’Orazio L.M. Pachicano M. Sepehrband F. Nelson A.R. Buennagel D.P. Harrington M.G. Benzinger T.L.S. Fagan A.M. Ringman J.M. Schneider L.S. Morris J.C. Chui H.C. Law M. Toga A.W. Zlokovic B.V. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat. Med. 2019 25 2 270 276 10.1038/s41591‑018‑0297‑y 30643288
    [Google Scholar]
  50. Bhale A.S. Venkataraman K. Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics. Biomed. Pharmacother. 2022 154 113634 10.1016/j.biopha.2022.113634 36063649
    [Google Scholar]
  51. Li S. Jia Y. Xue M. Hu F. Zheng Z. Zhang S. Ren S. Yang Y. Si Z. Wang L. Guan M. Xue Y. Inhibiting Rab27a in renal tubular epithelial cells attenuates the inflammation of diabetic kidney disease through the miR-26a-5p/CHAC1/NF-kB pathway. Life Sci. 2020 261 118347 Epub ahead of print10.1016/j.lfs.2020.118347 32853650
    [Google Scholar]
  52. Li H. Yang T. Fei Z. miR 26a 5p alleviates lipopolysaccharide induced acute lung injury by targeting the connective tissue growth factor. Mol. Med. Rep. 2020 23 1 1 Epub ahead of print10.3892/mmr.2020.11643
    [Google Scholar]
  53. Chen Y. Zhou X. Wu Y. The miR-26a-5p/IL-6 axis alleviates sepsis-induced acute kidney injury by inhibiting renal inflammation. Ren. Fail. 2022 44 1 551 561 10.1080/0886022X.2022.2056486 35491874
    [Google Scholar]
  54. Ghafouri-Fard S. Harsij A. Farahzadi H. Hussen B.M. Taheri M. Mokhtari M. A concise review on the role of MIR100HG in human disorders. J. Cell. Mol. Med. 2023 27 16 2278 2289 10.1111/jcmm.17875 37487022
    [Google Scholar]
  55. Wu Y. Wang Z. Yu S. Liu D. Sun L. LncmiRHG-MIR100HG: A new budding star in cancer. Front. Oncol. 2022 12 997532 Epub ahead of print10.3389/fonc.2022.997532 36212400
    [Google Scholar]
  56. Rohm T.V. Meier D.T. Olefsky J.M. Donath M.Y. Inflammation in obesity, diabetes, and related disorders. Immunity 2022 55 1 31 55 10.1016/j.immuni.2021.12.013 35021057
    [Google Scholar]
  57. Tan B.L. Norhaizan M.E. Effect of high-fat diets on oxidative stress, cellular inflammatory response and cognitive function. Nutrients 2019 11 11 2579 Epub ahead of print 10.3390/nu11112579 31731503
    [Google Scholar]
  58. Hourigan S.T. Solly E.L. Nankivell V.A. Ridiandries A. Weimann B.M. Henriquez R. Tepper E.R. Zhang J.Q.J. Tsatralis T. Clayton Z.E. Vanags L.Z. Robertson S. Nicholls S.J. Ng M.K.C. Bursill C.A. Tan J.T.M. The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis. Sci. Rep. 2018 8 1 13596 10.1038/s41598‑018‑32016‑x 30206364
    [Google Scholar]
/content/journals/cac/10.2174/0115734110374941250717134147
Loading
/content/journals/cac/10.2174/0115734110374941250717134147
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test